Takao Tsuneki

Dr. Takao Tsuneki

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in International Journal of Surgery Case Reports
Verified
Journal Article
Open access
TTTakao Tsuneki
Takao Tsuneki
YYYasuhiro Yuasa
Yasuhiro Yuasa
MFMizuki Fukuta
Mizuki Fukuta
HMHidenori Maki
Hidenori Maki
YMYuta Matsuo
Yuta Matsuo
TOTakashi Otani
Takashi Otani
Introduction: Secondary aorto-duodenal fistula (sADF) is a complication of abdominal aorta artificial blood vessel replacement that often leads to death. However, an optimal operative method has not yet been established. We describe a patient who underwent artificial blood vessel reimplantation and duodenectomy after endovascular aneurysmal repair (EVAR) with positive outcomes. Presentation of case: An 84-year-old man underwent artificial blood vessel replacement in 2015. In September 2016, he visited our emergency department and was diagnosed with sADF based on computed tomography. Urgent EVAR was performed, followed by duodenal segmental resection on the next day without opening the syringeal part to minimize the pollution of the operative field. Artificial blood vessel reimplantation and omental flap transposition were performed. As of 2020, about 3 years after surgery, there has been no relapse of the infection. Discussion: Using our novel operative method, we can minimize exposure of the artificial blood vessel and surrounding tissue to intestinal juice and pus. We believe that this reduces the risk of postoperative artificial blood vessel reinfection. Conclusion: Controlling bleeding by EVAR and resection of the duodenum and artificial blood vessels as a group without opening the syringeal part can contribute to positive long-term results as this method minimizes the pollution of the duodenectomy surgical field. Highlights:

1 January 2020 in International Journal of Surgery Case Reports
Verified
Journal Article
Open access
MFMizuki Fukuta
Mizuki Fukuta
ATAtsushi Tomibayashi
Atsushi Tomibayashi
TTTakao Tsuneki
Takao Tsuneki
KNKohei Nishioka
Kohei Nishioka
YMYuta Matsuo
Yuta Matsuo
YYYasuhiro Yuasa
Yasuhiro Yuasa
Introduction: Pancreatoduodenectomy (PD) after gastrectomy requires more attention during surgery than ordinary PD due to anatomical variation with different types of gastrointestinal anastomoses, the complication of anatomical dissection, and the extent of adhesions present. Herein, we describe the PD strategies we used in three patients who strategy for three patients who had previously undergone distal gastrectomy for gastric cancer treatment. Discussion: Generally, reconstruction following PD in patients who have undergone a prior Billroth I reconstruction is simple, as there is no previous afferent loop. By comparison, reconstruction after a Billroth II or R-Y reconstruction requires special consideration of the point of circulation and length of the remnant intestine used for pancreaticojejunostomy, choledochojejunostomy or gastrojejunostomy. Conclusion: There is no consensus regarding the best method for performing PD and reconstruction in patients with a prior history of gastrectomy. The appropriateness of using the existing afferent loop for reconstruction depends on whether the jejunum is of sufficient length for bile duct and pancreatic anastomosis. Regardless of the approach used, it is necessary to avoid excessive tension during reconstruction. Based on our experience and previous studies published in the English literature, we propose that reconstruction needs to be considered on a case-by-case basis. Highlights:

4 May 2022 in International Journal of Surgery Case Reports
Verified
Journal Article
Open access
TTTakao Tsuneki
Takao Tsuneki
YYYasuhiro Yuasa
Yasuhiro Yuasa
TNTakeshi Nishino
Takeshi Nishino
ATAtsusi Tomibayashi
Atsusi Tomibayashi
TMTatsuo Motoki
Tatsuo Motoki
YFYoshiaki Fukumura
Yoshiaki Fukumura
Introduction and importance: Secondary aortoduodenal fistula (sADF) is a complication of prosthetic graft replacement of the abdominal aorta which often follows a fatal course. This report details our experience with a case of lymphatic fistula that developed after sADF repair. The fistula was refractory to conservative treatment but ultimately responded to lipiodol lymphangiography. Case presentation: A 75-year-old man had undergone prosthetic graft replacement to treat an abdominal aortic aneurysm in 2012 and a thoracic aortic aneurysm in 2015. Upper gastrointestinal endoscopy was performed in 2020, and examination for worsening anemia revealed that the abdominal aortic graft had eroded into the horizontal duodenum. The patient was treated with prosthetic graft replacement and duodenectomy. A refractory lymphatic fistula was noted after surgery, which made ascites accumulation difficult to control, but the patient's condition rapidly improved following therapeutic lymphangiography. Clinical discussion: Surgery is the first-line therapy for sADF, but clinicians must stay vigilant for infection recurrence and aortoenteric fistulae after a repair, and this requires patient-specific postoperative management. Our modifications, intended to minimize contamination of the operative field in the present case, also facilitated our ability to subsequently treat a refractory lymphatic fistula, which is a rare postoperative complication of the procedure. Conclusion: Procedural modifications to sADF repair aimed at minimizing perioperative contamination are crucial for preventing infection recurrence. Given the extent of invasion, the surgery can cause various postoperative complications, requiring individualized strategies for management and treatment. Therapeutic lymphangiography is one such approach, which holds promise as a first-line treatment for refractory lymphatic fistula. Highlights:

1 April 2020 in The Japanese Journal of Gastroenterological Surgery
Verified
Journal Article
Open access
PDF file
TTTakao Tsuneki
Takao Tsuneki
YYYasuhiro Yuasa
Yasuhiro Yuasa
HMHidenori Maki
Hidenori Maki
TTTaihei Takeuchi
Taihei Takeuchi
YMYuta Matsuo
Yuta Matsuo
YFYoshiyuki Fujii
Yoshiyuki Fujii
症例は70歳の男性で,上部消化管内視鏡にて胃角部小彎に0-IIa+IIc型早期胃癌を指摘され,当科を紹介受診した.腹腔鏡下幽門側胃切除を施行し病理結果は以下であった〔pT1bN2M0,pStage IIA,HER2(IHC2+,FISH陽性)〕.術後経過観察を行ったが,8か月後に肝外側区域に異時性肝転移が出現した.S-1+cisplatin+trastuzumab療法を3コース施行し,腫瘍縮小効果が得られた.新規病変の出現も認めなかったため腹腔鏡下肝部分切除を施行した.術後,S-1を1年間内服し約4年経過した現在も無再発生存中である.HER2陽性胃癌術後の単発肝転移に対して化学療法後に腹腔鏡下肝部分切除を施行した1例を経験したので報告する.

19 May 2026 in Cancers
Verified
Journal Article
Open access
PDF file
TTTakao Tsuneki
Takao Tsuneki
MSMasafumi Saito
Masafumi Saito
Kimihiro YamashitaKimihiro Yamashita
Kimihiro Yamashita
MAMasayuki Ando
Masayuki Ando
KYKeisuke Yasuda
Keisuke Yasuda
YKYoshihiro Kakeji
Yoshihiro Kakeji
Backgrou nd: Aging profoundly alters host immunity, yet how age-associated immune changes in the liver influence the growth of metastatic tumors remains incompletely understood. Liver metastasis is a major cause of cancer-related mortality, particularly in elderly patients, for whom aggressive treatments are often not feasible. This study aimed to clarify how aging reshapes the hepatic immune microenvironment and to identify age-associated host factors that influence liver metastasis growth. Methods: Tumor-naïve and tumor-bearing young and aged mice were analyzed using a syngeneic MC38 liver metastasis model. Immune cell composition in the liver was assessed by flow cytometry, and gene expression was evaluated by quantitative reverse transcription PCR (RT–qPCR). Public transcriptomic datasets were screened to identify age-associated inflammatory factors. The functional relevance of the S100A8/A9 axis was examined using the small-molecule inhibitor paquinimod. Results: Aging was associated with a distinct baseline immune cell composition in the liver. During liver metastasis, overall growth was comparable between young and aged mice; however, metastatic lesions in aged hosts showed increased expression of multiple inflammation-related genes and prominent accumulation of Ly6G+ cells. In silico screening identified S100a9 as one of the most highly upregulated inflammation-related genes in aged livers, which was confirmed in both tumor-naïve and metastatic liver tissues. Pharmacological modulation of the S100A8/A9 axis with paquinimod significantly reduced liver metastasis growth in aged, but not young, mice, and was accompanied by a shift in immune cell composition, including an increased representation of CD8+ T cells. Conclusions: These findings indicate that aging is associated with a distinct hepatic immune context that shapes the inflammatory and cellular composition of the tumor microenvironment during liver metastasis. S100A9 emerges as a key age-associated, host-derived factor that is functionally relevant to the growth of liver metastases in aged hosts, supporting the S100A8/A9 axis as a context-specific therapeutic target.